HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paulien Gm Ravenstijn Selected Research

Biomarkers (Surrogate Marker)

2/2012Evaluation of blood-brain barrier transport and CNS drug metabolism in diseased and control brain after intravenous L-DOPA in a unilateral rat model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paulien Gm Ravenstijn Research Topics

Disease

1Parkinson Disease (Parkinson's Disease)
02/2012

Drug/Important Bio-Agent (IBA)

1Levodopa (L Dopa)FDA LinkGeneric
02/2012
1RotenoneIBA
02/2012
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
02/2012
13,4-Dihydroxyphenylacetic AcidIBA
02/2012
1Biomarkers (Surrogate Marker)IBA
02/2012